‘AstraZeneca vaccine increases another rare blood clot risk’
New research from Flinders University and international experts shows that PF4 antibodies in both adenovirus infection-associated VITT and classic adenoviral vector VITT have identical molecular signatures…reports Asian Lite News British-Swedish pharma giant
